Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Kees

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
Arzneimittel-Forschung|April 1, 1996
Bioavailability of cefpodoxime proxetil with co-administered acetylcysteineF Kees, M Wellenhofer, K Bröhl, et al.
Geburtshilfe Und Frauenheilkunde|July 1, 1993
[Clarithromycin, a new macrolide antibiotic. Effectiveness in puerperal infections and pharmacokinetics in breast milk]T Sedlmayr, F Peters, W Raasch, et al.
Arzneimittel-Forschung|May 1, 1992
Cardiovascular parameters and catecholamines in volunteers during passive orthostasis. Influence of antihypotensive drugsP Dominiak, F Kees, D Welzel, et al.
Transplantation Proceedings|February 3, 2005
Cicloral versus neoral: a bioequivalence study in healthy volunteers on the influence of a fat-rich meal on the bioavailability of cicloralF Kees, G Mair, M Dittmar, et al.
Alimentary Pharmacology & Therapeutics|June 10, 2000
Influence of age on the steady state disposition of drugs commonly used for the eradication of Helicobacter pyloriS Ammon, G Treiber, F Kees, et al.
Journal of Chromatography|February 23, 1990
High-performance liquid chromatographic assay for cefotiam and d3-cefotiam in human serumF Kees, W Raasch, M Steger, et al.
Arzneimittel-Forschung|May 1, 1986
Inhibition of monoamine oxidase by viloxazine in ratsC Martinez, P Dominiak, F Kees, et al.
Arzneimittel-Forschung|August 1, 1991
Comparative investigations on the bioavailability of cefuroxime axetilF Kees, U Lukassek, K G Naber, et al.
Chemotherapy|January 1, 1988
Penetration of fleroxacin into prostatic secretion and prostatic adenoma tissueF Kees, K G Naber, H Schumacher, et al.
Journal of Hypertension|February 12, 1998
Role of sympathetic nerves for the stimulation of the renin system by angiotensin II receptor blockadeC Wagner, F Kees, B K Krämer, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Arzneimittel-Forschung|April 1, 1996
Bioavailability of cefpodoxime proxetil with co-administered acetylcysteineF Kees, M Wellenhofer, K Bröhl, et al.
Geburtshilfe Und Frauenheilkunde|July 1, 1993
[Clarithromycin, a new macrolide antibiotic. Effectiveness in puerperal infections and pharmacokinetics in breast milk]T Sedlmayr, F Peters, W Raasch, et al.
Arzneimittel-Forschung|May 1, 1992
Cardiovascular parameters and catecholamines in volunteers during passive orthostasis. Influence of antihypotensive drugsP Dominiak, F Kees, D Welzel, et al.
Transplantation Proceedings|February 3, 2005
Cicloral versus neoral: a bioequivalence study in healthy volunteers on the influence of a fat-rich meal on the bioavailability of cicloralF Kees, G Mair, M Dittmar, et al.
Alimentary Pharmacology & Therapeutics|June 10, 2000
Influence of age on the steady state disposition of drugs commonly used for the eradication of Helicobacter pyloriS Ammon, G Treiber, F Kees, et al.
Journal of Chromatography|February 23, 1990
High-performance liquid chromatographic assay for cefotiam and d3-cefotiam in human serumF Kees, W Raasch, M Steger, et al.
Arzneimittel-Forschung|May 1, 1986
Inhibition of monoamine oxidase by viloxazine in ratsC Martinez, P Dominiak, F Kees, et al.
Arzneimittel-Forschung|August 1, 1991
Comparative investigations on the bioavailability of cefuroxime axetilF Kees, U Lukassek, K G Naber, et al.
Chemotherapy|January 1, 1988
Penetration of fleroxacin into prostatic secretion and prostatic adenoma tissueF Kees, K G Naber, H Schumacher, et al.
Journal of Hypertension|February 12, 1998
Role of sympathetic nerves for the stimulation of the renin system by angiotensin II receptor blockadeC Wagner, F Kees, B K Krämer, et al.
Pageof 8